Chou An-Hsun, Chen Tien-Hsing, Chen Chun-Yu, Chen Shao-Wei, Lee Chao-Wei, Liao Chien-Hung, Wang Shang-Yu
Department of Anesthesiology, Chang Gung Memorial Hospital, Linkou Medical Center, Chang Gung University.
Circ J. 2017 Mar 24;81(4):476-484. doi: 10.1253/circj.CJ-16-0849. Epub 2017 Feb 3.
Patients with liver cirrhosis (LC) have a higher risk for cardiac surgery, but population-based long-term follow-up studies are lacking. The aim of this study was therefore to validate the long-term outcome of cardiac surgery in patients with LC.
Data were obtained from Taiwan's National Health Insurance Database, 1997-2011. This study included 1,040 LC patients and 1,040 matched controls without LC. The actuarial survival rate at 1, 5 and 10 years in the LC cohort was 68%, 50% and 41%: significantly lower than that of the control cohort at 81%, 68% and 62% at 1, 5 and 10 years after cardiac surgery. Compared with the matched control cohort, the LC group had a higher risk of liver and heart failure readmission (P<0.001) during the follow-up period. In addition, the LC cohort had a higher risk of liver causes of death than did the control cohort (12.6% vs. 1.2%). In the LC cohort, 51% of deaths were due to hepatocellular carcinoma. And in the LC group, those with valve surgery and advanced cirrhosis had a lower survival rate (P=0.002, P=0.001).
Even after successful cardiac surgery, long-term outcome is unsatisfactory in LC patients because of the progressive deterioration of liver function.
肝硬化(LC)患者进行心脏手术的风险较高,但缺乏基于人群的长期随访研究。因此,本研究的目的是验证LC患者心脏手术的长期预后。
数据来源于1997 - 2011年台湾国民健康保险数据库。本研究纳入了1040例LC患者和1040例匹配的无LC对照者。LC队列1年、5年和10年的精算生存率分别为68%、50%和41%,显著低于心脏手术后1年、5年和10年对照队列的81%、68%和62%。与匹配的对照队列相比,LC组在随访期间因肝衰竭和心力衰竭再次入院的风险更高(P<0.001)。此外,LC队列因肝脏原因导致的死亡风险高于对照队列(12.6%对1.2%)。在LC队列中,51%的死亡归因于肝细胞癌。在LC组中,接受瓣膜手术和晚期肝硬化患者的生存率较低(P = 0.002,P = 0.001)。
即使心脏手术成功,由于肝功能的进行性恶化,LC患者的长期预后仍不令人满意。